Expression levels of FGFR3 as a prognostic marker for the progression of primary pT1 bladder cancer and its association with mutation status

The present study examined the utility of fibroblast growth factor receptor 3 (FGFR3) mutation status and gene expression as a prognostic marker in primary pT1 bladder cancer (BC). A total of 120 patients with primary pT1 BC were enrolled. FGFR3 mutation status was determined by direct sequencing an...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Kang, Ho Won, Kim, Ye-Hwan, Jeong, Pildu, Park, Cheol, Kim, Won Tae, Ryu, Dong Hee, Cha, Eun-Jong, Ha, Yun-Sok, Kim, Tae-Hwan, Kwon, Tae Gyun, Moon, Sung-Kwon, Choi, Yung Hyun, Yun, Seok-Joong, Kim, Wun-Jae
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2017
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5587943/
https://ncbi.nlm.nih.gov/pubmed/28927152
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.6621
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia